6-Tioinozinska kiselina
Tioinozinska kiselina je intermedijar u metabolizmu azatioprina.[3] Azatioprin[4] je imunosupresivni lek koji se koadministrira sa ciclosporinom i kortikosteroidima da bi se sprečilo neprihvatanje transplantacije organa[5]. Azatioprin, prolek 6-mercaptopurina (6-MP), dejstvuje kao antimetabolit purina nakon intracelularne konverzije hipoksantinguanin fosforibosil transferazom u 6-tioinosine monofosfat (6-TIMP).
Nazivi | |
---|---|
IUPAC naziv
[(2R,3S,4R,5R)-3,4-Dihidroksi-5-(6-sulfaniliden-3H-purin-9-il)oksolan-2-il]metil dihidrogen fosfat
| |
Identifikacija | |
3D model (Jmol)
|
|
ECHA InfoCard | 100.000.168 |
| |
Svojstva | |
C10H13N4O7PS | |
Molarna masa | 364,27 g/mol |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
Reference infokutije | |
Reference
уреди- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ L Fletcher & J L Maddocks (1980). „Assay of thioinosinic acid, an active metabolite of azathioprine, in human lymphocytes.”. Br J Clin Pharmacol. 10 (3): 287—292.
- ^ Thomas L. Lemke; David A. Williams, ур. (2002). Foye's Principles of Medicinal Chemistry (5. изд.). Baltimore: Lippincott Willams & Wilkins. стр. 785—6. ISBN 0781744431.
- ^ Simmonds RL, Canafax DM, Fryd SD, Asher NL, Payne WD, Sutherland DE, Narajan JS (1986). „New immunosuppressive drug combination for mismatched related and cadaveric renal transplantation”. Transplant Proc. 18: 76—81.